Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent

Details for Australian Patent Application No. 2006218177 (hide)

Owner Chiesi Farmaceutici S.p.A.

Inventors Meakin, Brian John; Delcanale, Maurizio; Pivetti, Fausto; Lewis, David Andrew

Agent Spruson & Ferguson

Pub. Number AU-B-2006218177

PCT Pub. Number WO2006/089656

Priority 05004233.2 25.02.05 EP

Filing date 13 February 2006

Wipo publication date 31 August 2006

Acceptance publication date 12 April 2012

International Classifications

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

A61K 9/72 (2006.01) Medicinal preparations characterised by special physical form - for smoking or inhaling

A61K 31/4704 (2006.01) - 2-Quinolinones, e.g. carbostyril

A61K 31/573 (2006.01)

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61K 47/02 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

Event Publications

9 August 2007 PCT application entered the National Phase

  PCT publication WO2006/089656 Priority application(s): WO2006/089656

12 April 2012 Application Accepted

  Published as AU-B-2006218177

9 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006218179-NK1 antagonists

2006218175-Plasterboards provided with antimicrobial effect